DNA Ploidy in Endometrial Carcinoma: Major Objective Prognostic Factor
- 1 May 1990
- journal article
- research article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 65 (5) , 643-650
- https://doi.org/10.1016/s0025-6196(12)65126-x
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Evaluation of unfavorable histologic subtypes in endometrial adenocarcinomaAmerican Journal of Obstetrics and Gynecology, 1990
- Prognostic significance of positive peritoneal cytology in endometrial carcinomaAmerican Journal of Obstetrics and Gynecology, 1988
- Peritoneal cytology in patients with endometrial carcinomaGynecologic Oncology, 1988
- Results of therapy, analysis of failures, and prognostic factors for clinical and pathologic stage III adenocarcinoma of the endometriumGynecologic Oncology, 1987
- Prognostic Factors in Early Carcinoma of the EndometriumAmerican Journal of Clinical Oncology, 1987
- Adenocarcinoma corpus et colli: Analysis of diagnostic variablesInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Influence of cytoplasmic steroid receptor content on prognosis of early stage endometrial carcinomaAmerican Journal of Obstetrics and Gynecology, 1985
- Risk factors and recurrent patterns in Stage I endometrial cancerAmerican Journal of Obstetrics and Gynecology, 1985
- Cytosol estrogen and progestin receptors in endometrial carcinoma of patients treated with surgery, radiotherapy, and progestin. Clinical correlatesCancer, 1982
- Adenocarcinoma of the endometrium: Analysis of 256 cases with carcinoma limited to the uterine corpusGynecologic Oncology, 1982